Defining a Role of Amanita phalloides Toxins in Cancer: Research and Therapy
PDF

Keywords

Amatoxins
Amanita phalloides
cancer therapy

How to Cite

Talib, N. (2021). Defining a Role of Amanita phalloides Toxins in Cancer: Research and Therapy. Journal of Life and Bio Sciences Research , 2(01), 07 - 12. https://doi.org/10.38094/jlbsr20137

Abstract

Despite the progress of diagnostic and therapy, the cancer burden is still rising worldwide. The new chemotherapeutical toxicity to somatic cells and its tolerance to tumor cells illustrates the immediate demand through recent pharmaceutical products with less harmful impacts. The use of natural anticancer products, like alpha-amanitin toxins have reached the cancer field therapy since the separation of Amanita phalloides fungi was performed. Application of Amanita phalloides affects tumor cell activity. It is thought that Amanita phalloides dilutions are recommended for a patient suffering from various cancer types and have no severe side effects resulting from amanita therapy. This review aims to explain the use of the therapeutic potential of -amanitin toxin against different cancer types.

https://doi.org/10.38094/jlbsr20137
PDF

References

Bambauer, T.P., Wagmann, L., Weber, A.A., and Markus, R. M. (2020). Analysis of and -amanitin in Human Plasma at Subnanogram per Milliliter Levels by Reversed Phase Ultra- High Performance Liquid Chromatography Coupled to Orbitrap Mass Spectrometry. Toxins, 12, 671.

Baumgä²´ner, E., Schyska, R., Binscheck, T. (2011). Analyzing the diagnostic value of Amatoxin-ELISA in mushroom poisoning. Clin. Toxicol, 49.

Becker, C.E., Tong, T.G., Boerner, U. (1976). Diagnosis and Treatment of Amanita Phalloides-Type Mushroom Poisoning: Use of Thioctic Acid. West. J. Med., 125, 100-109.

Berch, SM., Kroeger, P., Finston, I. (2007). The death cap mushroom (Amanita phalloides) moves to a native tree in Victoria, British Columbia., Botany, 95, 435-440.

Beug, B. M., Shaw, M., Cochran, K. (2006). Thirty Plus Years of Mushroom Poisoning: Summary of the Approximately 2000 Reports in the NAMA Case Registry., Mcllvainea, 16,47-68.

Bever, C.S., Swanson, K.D., Hamelin, E.I., Filigenzi, M., Poppenga, R.H., Kaae, J., Cheng, L.W., Stanker, L.H. (2020). Rapid, sensitive, and accurate point-of-care detection of lethal amatoxins in urine. Toxins, 12(2), 123, 10 pp.

Broussard, C.N., Aggarwal, A., Lacey, S. (2001). Mushroom Poisoningfrom Diarrhea to Liver Transplantation. Am. J. Gastroenterol., 96, 3195-3198.

Brnn, O., Meder, M., Freitag, R. (1996). Analysis of Amatoxins Alpha-Amanitin and Beta-Amanitin in Toadstool Extracts and Body Fluids by Capillary Zone Electrophoresis with Photodiode Array Detection. J. Chromatogr. A., 744, 167-176.

Cai, Q., Cui, Y.Y., Yang, Z.L. (2016). Lethal Amanita species in China. Mycologia, 108(5), 993-1009.

De Olano, J., Wang, J.J., Villeneuve, E., Gosselin, S., Biary, R., Su, M.K., Hoffman, R.S. (2020). Current fatality rate of suspected cyclopeptide mushroom poisoning in the United States. Clin. Toxicol., 1-4.

Diaz, J.H. (2018). Amatoxin-containing mushroom poisonings: Species, toxidromes, treatments, and outcomes. Wilderness Environ. Med., 29(1),111-118.

Edward, T. R., David, R. H., Tom, S., Naomi, E. A., Timothy, P. E. (2020). Hunter's Tropical Medicine and Emerging Infectious Diseases (Tenth Edition), Elsevier, 1006-1020.

Enjalbert, F., Rapior, S., Nouguier-Soulé¬ J. (2002). Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis. J. Toxicol. Clin. Toxicol., 40, 715-757.

Escudié¬ L., Francoz, C., Vinel, JP., Moucari, R., Cournot, M., Paradis, V., Sauvanet, A., Belghiti, J., Valla, D., Bernuau, J. and Durand. F. (2007). Amanita phalloides poisoning: Reassessment of prognostic factor and indications for emergency liver transplanation. J, Hepatol, 46, 466-73.

Faulstich, H. (1979). New aspects of amanita poisoning. Klin. Wochenschr., 57, 1143-1152.

Faulstich, H. (1980). Mushroom Poisoning. Lancet, 2, 794-795.

Fiume, L., Marinozzi, V., Nardi, F. (1969). The Effects of Amanitin Poisoning on Mouse Kidney. Br. J. Exp. Pathol., 50, 270-276.

Flament, E., Guitton, J., Gaulier J-M, Gaillard Y. (2020). Human Poisoning from Poisonous Higher Fungi: Focus on Analytical Toxicology and Case Reports in Forensic Toxicology. Pharmaceutical, 454, 12 (13).

Garcia, J., Costa, VM, Baptista, P., Lourdes Bastos, M., Carvalho, F. (2015a). Quantification of alpha-amanitin in biological samples by HPLC using simultaneous UV- diode array and electrochemical detection. J Chromatogr B Anal Technol Biomed Life Sci, 997, 85-95.

Garcia, J., Costa, VM., Carvalho, A., Baptista, P., de Pinho, P.G., de Lourdes Bastos, M., Carvalho, F. (2015b). Amanita phalloides poisoning: mechanisms of toxicity and treatment. Food Chem Toxicol, 86, 41-55.

Garcia, J., Oliveira, A., de Pinho, P.G., Freitas, V., Carvalho, A., Baptista, P., Pereira, E., de Lourdes Bastos, M., Carvalho, F. (2015c). Determination of amatoxins and phallotoxins in Amanita phalloides mushrooms from northeastern Portugal by HPLC-DAD-MS. Mycologia, 107(4), 679-687.

Horowitz, B.Z., Moss, M.J. (2020). Amatoxin mushroom toxicity. StatPearls Publ., Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK431052.

Hu, J., Zhang, P., Zeng, J. (2012). Determination of Amatoxins in Differerent Tissues and Development Stages of Amanita Exitialis. J. Sci. Food Agric., 92, 2664-2667.

Jander, S. Bischoff, J., Woodcock, BG. (2000). Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Ther Apher., 4(4), 308-312.

Jander, S., Bischoff, J. (2000). Treatment of Amanita phalloides poisoning: I. Retrospective evaluation of plasmapheresis in 21 patients. Ther Apher. 4(4), 303-307.

Kieslichova, E., Frankova, S., Protus, M., Merta, D., Uchytilova, E., Fronek, J. Sper, J. (2018). Acute liver failure due to Amanita phalloides poisoning: Therapeutic approach and outcome. Transplant, Proc, 50, 192-197.

Klein, A.S., Hart, J., Brems, J.J. (1989). Amanita Poisoning: Treatment and the Role of Liver Transplantation. Am. J. Med., 86, 187193.

Kubicka, J. (1968). Traitement des empoisonnements fongiques phalloidiniens en Tchecoslovaquie [Treatment of phalloides- related poisonings in Tchecoslovaquia. Acta Mycol., 4, 373-377.

Kume, K., Ikeda, M., Miura, S., Kume, K., Ikeda, M., Miura, S., Ito, K., Sato, K.A., Ohmori, Y., Endo, F.,Katagiri, H., Ishida, K., Ito, C., Iwaya, T., Nishizuka, S.S. (2016). -Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15. Sci Rep 6, 25895.

Litten, W. (1975). The most poisonous mushrooms, Sci. Am., 232, 90-101.

Liu, Y., Zhang, X., Han, C., Wan, G., Huang, X., Ivan, C., Jiang, D., Rodriguez-Aguayo, C., Lopez-Berestein, G., Rao, PH., Maru, DM., Pahl, A., He, X., Sood AK, Ellis, LM., Anderl, J., Lu, X. (2015). TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature, 30, 520(7549), 697-701.

Loizides, M., Bellanger, J.M., Yiangou, Y., Moreau, P.A. (2018). Preliminary phylogenetic investigations into the genus Amanita(Agaricales) in Cyprus, with a review of previous records and poisoning incidents. Documents, Mycologiques., 37, 201-218.

Matinkhoo, K., Pryyma, A., Todorovic, M., Patrick, B.O., Perrin, D.M. (2018). Synthesis of the Death-Cap Mushroom Toxin -Amanitin. Journal of the American Chemical, Society., 140, (21), 6513-6517.

May, J.P., Fournier, P., Patrick, B.O., Perrin, D.M. (2008). Synthesis, characterisation, and In vitro evaluation of Pro2-Ile3- S-deoxo- amaninamide and Pro2-D-allo-Ile3-S-deoxo- amaninamide: implications for-structure-activity relationships in amanitin conformation and toxicity. Chemistry, 14, 3410- 3417.

Meunier, B.C., Camus, C.M., Houssin, D.P. (1995). Liver Transplantation after Severe Poisoning Due to Amatoxin- Containing LepiotaReport of Three Cases. J. Toxicol. Clin. Toxicol., 33, 165-171.

Moldenhauer, G., Salnikov, A.V., L, S., Herr, I., Anderl, J., Faulstich, H. (2012). Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma. J Natl Cancer Inst., 104, 622-634.

Moor-Smith, M., Li, R., Ahmed, O. (2019). The worlds most poisonous mushroom, Amanita phalloides, is growing in BC. B. C. Med. J, 61(1), 20-24.

Moroni, F., Fantozzi, R., Masini, E.A. (1976). Trend in the Therapy of Amanita Phalloides Poisoning. Arch. Toxicol., 36, 111-115.

Pahl, A., Lutz, C., Hechler, T. (2018). Amanitins and their development as a payload for antibody-drug conjugates. Drug Discov Today Technol, 30, 85-89.

Paul, A., Das, S., Das, J., Sammader, A., Khuda-Bukhsh, A.R. (2013). Cytotoxicity and apoptotic signaling cascade induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells In vitro and bioavailability of nano-chelidonine in mice in vivo. Toxicol. Lett., 222(1), 10-22.

Pulman, J.A., Childs, K.L., Sgambelluri, R.M., Walton, J.D. (2016). "Expansion and diversification of the MSDIN family of cyclic peptide genes in the poisonous agarics Amanita phalloides and A. bisporigera". BMC Genomics, 17 (1),1038.

Riede, I. (2007). The biochemistry of the tumor cell. Naturheilpraxis, 12, 1733-1743. (In German).

Riede, I. (2009). Amanita Therapie eines Mammakarzinoms. NATUR-Heilkunde, 32, 18.

Riede, I. (2010). Tumor therapy with Amanita phalloides (death cap): Stabilization of B-cell chronic lymphatic leukemia. J. Altern. Complement Med., 16(10), 1129-1132.

Riede, I. (2011). Tumor therapy with Amanita phalloides (Death Cap): Stabilization of mammary duct cancer. TANG: Intern. J. Genuine Trad. Med., 1(1), 5,1-5.3.

Riede, I. (2012a). Inhibition of apoptosis in ALL-1 leukemic cell lines: Allowance of replication, constant repair replication, defect DNA damage control. J. Cell Sci. Ther., 3(6), 133.

Riede, I. (2012b). Tumor therapy with Amanita phalloides (Death Cap): Long-term stabilization of prostate cancers. J. Integr. Oncol., 1(1), 3 -10.

Riede, I. (2013a). Switch the tumor off: From genes to Amanita therapy. Am. J. Biomed. Res., 1(4), 93-107.

Riede, I. (2013b). Tumor therapy with Amanita phalloides: Remission of a tumor disease and dietary effect of sugar. J. Cell Sci. Ther., 4(3),1000147, 3 pp.

Riede, I. (2015). Borrelia infection appears as chronic lymphocytic leukemia: Therapy with Amanita phalloides and Terebinthina laricina. Br. J. Med. Med. Res., 7(7), 630-637.

Riede, I. (2016). Stabilization of prostate cancer with Amanita phalloides: Intervals with 5-alpha-reductase inhibitors and melatonin to circumvent resistance: Case report: Br. J. Med. Med. Res., 17(5), 1-6.

Riede, I. (2017). New therapy strategy for prostate cancer: Amanita phalloides treatment stabilizes best without pre- treatments (observational study pre-protocol). Br. J. Med. Med. Res., 21(3), 1-7.

Riede. I. (2019). Amanita phalloides in Tumor Therapy: Stabilization of Pharyngeal Squamous Cell Carcinoma (Case Report). Acta Scientific Cancer Biology, 3(3), 70-73.

Rodrigues, D.F., Ricardo, P.d.N., Alexandra, T.P.C., Maria, L.Ba., Vendramin, A., Jamsek, M., Brvar, M. (2017). Amanita phalloides poisoning in Slovenia, 1999-2015. Clin. Toxicol., 55, 501.

Rodrigues, D.F., das Neves, R.P., Carvalho, A.T.P., Bastos, M.L., Costa, V.M., Carvalho, F. (2020). In vitro mechanistic studies on -amanitin and its putative antidotes. Arch. Toxicol., 94, 2061-2078.

Santi, L., Maggioli, C., Mastrorobeerto, M., Tufoni, M., Napoli, L., Caraceni, P., (2012). Acute Liver Failure Caused by Amanita phalloides Poisoning. Int J Hepatol., 31,480-487.

Song, F.Q., Liu, Y., Kong, X.S., Chang, W., Song, G. (2013). Progress on understanding the anticancer mechanisms of medicinal mushroom: ͮonotus obliquus. Asian Pac. J. Cancer Prev., 14(3), 1571-1578.

Tripathy, G., Pradhan, D. (2013). Evaluation of in-vitro anti- proliferative activity and in-vivo immunomodulatory activity of Beta vulgaris. Asian J. Pharm. Clin. Res., 6(Suppl. 1), 127-130.

Wauters, J.P., Rossel, C., Farquet, J.J. (1978). Amanita Phalloides Poisoning Treated by Early Charcoal Haemoperfusion. Br. Med. J., 2, 13-20

White, J., Weinstein, S., De Haro, L. (2019). Mushroom Poisoning: A Proposed New Clinical Classification. Toxicon , 157, 5365.

Wieland, T. (1983). The Toxic Peptides from Amanita Mushrooms. Int. J. Pept. Protein Res., 22, 257-276.

Wieland, T., Wieland, O. (1959). Chemistry and Toxicology of the Toxins of Amanita Phalloides. Pharmacol. Rev., 11, 87107.

Yilmaz, I., Ermis, F., Akata, I., Kaya, E. (2015). A case study: What doses of Amanita phalloides and amatoxins are lethal to humans? Wilderness Environ. Med., 26(4), 491-496.

Yin, X., Yang, A.A., Gao, J.M. (2019). Mushroom toxins: Chemistry and toxicology. J. Agric. Food Chem., 67(18), 5053-5071.

Zhang, P., Tang, L.P., Cai, Q., Xu, J.P. (2015). A review on the diversity, phylogeography and population genetics of Amanita mushrooms. Mycology, 6(2), 86-93.

Zilker, T., Faulstich, H. (2017). Cyclopeptide-containing mushrooms: The deadly Amanitas. In: Brent J, Burkhart K, Dargan P, et al. (eds). Critical care toxicology. 2nd ed; New York: Springer; p. 2129-2148.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2021 Array